Eli Lilly, Boehringer Ingelheim launch educational program for healthcare professionals
INDIANAPOLIS — Drug makers Boehringer Ingelheim and Eli Lilly have started a campaign designed to educate healthcare professionals about the role a type of protein plays in maintaining blood-sugar balance.
BI and Lilly created the website sglt.com to inform users about the role of sodium glucose co-transporters. The program also includes a video, Glucose Perspectives, in the form of a sketch animation by the United Kingdom’s Royal Society for the Encouragement of Arts, Manufactures and Commerce.
SGLTs work by ensuring that glucose entering the kidneys finds its way back into the bloodstream instead of being passed in urine. SGLT1 and SGLT2 reabsorb nearly all the filtered glucose in the kidneys, with SGLT2 accounting for 90% of reabsorption, according to a 2008 study.
In March, the drug makers applied with the Food and Drug Administration for approval of empagliflozin, a drug that belongs to a new class called SGLT2 inhibitors. The partnership between the two companies was announced in January 2011.
Are you a nurse practitioner or physician’s assistant? Join our Facebook group to get all the latest news dedicated to delivering healthcare services to patients in retail pharmacy clinics.
NACDS joins ‘Partnership for Advancing Medication Adherence’
ARLINGTON, Va. — The National Association of Chain Drug Stores has announced its membership in “Prescriptions for a Healthy America: A Partnership for Advancing Medication Adherence."
” The Partnership launched on Thursday to bring together patient, provider, employer, pharmacy and health plan advocates to work closely with policymakers in Washington, D.C., to improve medication adherence. According to NEHI, formerly the New England Healthcare Institute, non-adherence has been estimated to impose $290 billion in avoidable healthcare costs annually.
The Partnership also released poll results that found that nearly two-thirds of patients who take medication do not properly adhere to prescription regimens. The poll also found that more than half of respondents said they would be more likely to take their medications as prescribed if they were more informed about the potential negative health consequences of non-adherence.
“At NACDS, we are seeing ever-greater awareness among policymakers about the benefits of boosting medication adherence, and the launch of the Partnership is ideally timed to help build that momentum for the good of patient health,” stated NACDS president and CEO Steve Anderson. “We appreciate the opportunity to work shoulder-to-shoulder with the Partnership members on an issue that rightfully could be considered one of the most pressing health challenges and opportunities of the day.
“NACDS’ research fits nicely with the poll results released by the Partnership. Polls commissioned by NACDS and by others have shown consistently that community pharmacists are widely trusted and accessible, and that face-to-face interactions with pharmacists are extremely valued, particularly by those in greatest need. Patients know that community pharmacies play a vital role in helping patients use medicines as prescribed and safely, and in helping patients stay healthy. NACDS members can and do play a vital role in the mission that the Partnership is pursuing."
In addition to noting its own opinion research, NACDS has emphasized that, in late 2012, the Congressional Budget Office announced steps to reflect in its cost-evaluation of legislative proposals the belief that better use of medications can generate savings by reducing reliance on costly forms of care. If generalized to the nation as a whole, just a 1% increase in medication use saves $1.7 billion in overall healthcare costs, or $5.76 per person.
Also, the Centers for Medicare & Medicaid Services in February released a study focused on Medicare beneficiaries with certain lung or heart conditions. Those enrolled in medication therapy management services in 2010 — and particularly those who received comprehensive medication reviews — experienced significant improvement in the quality of their drug regimens and costs were saved.
“In the effort to help boost medication adherence through healthcare practice, patient awareness and public policy, there is no more committed partner than NACDS and community pharmacy, and we are enthusiastic to be part of the Partnership’s launch today,” Anderson said.
RxResults picks Mirixa for MTM program
RESTON, Va. — A company that manages pharmacy services for employer groups and health plans has selected a company founded by the National Community Pharmacists Association for its medication therapy management services.
RxResults said it had chosen Mirixa Corp.’s MirixaPro platform to administer MTM services for members of its employer groups. The services will include a person-to-person comprehensive medication review and quarterly interactive follow-up medication reviews delivered by a pharmacist using the platform.
"RxResults wants to provide more employees and their families access to pharmacist-provided MTM services," RxResults president and CEO Tery Baskin said. "Our focus will be to close gaps in care to improve medication adherence and empower patients to self-manage their medical conditions."